Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses the EUMDS trial (NCT00600860). Specifically, the role of EUMDS to log clinical information of diagnosis, treatments, and effects of these treatments in elderly myelodysplastic syndrome (MDS) patients. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.